Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 454-457 , December 2009

Three-dimensional conformal radiation therapy for squamous cell carcinoma of the esophagus: A prospective phase I/II study

Received 21 March 2009 ,Revised 22 October 2009 ,Accepted 22 October 2009.

References 

  1. Coia LR, Minsky BD, John MJ, et al. The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: results of the 1992–1994 patterns of care study. Cancer. 1999;85:2499–2505
  2. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999;28:1623–1627
  3. Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593–1598
  4. Coia L, Engstrom P, Paul A, et al. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys. 1991;20:29–36
  5. Leichman L, Herskovic A, Leichman C, et al. Nonoperative therapy for squamous-cell cancer of the esophagus. J Clin Oncol. 1987;5:365–370
  6. Seitz J, Giovannini M, Padaut-Cesana J, et al. Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy. Cancer. 1990;66:214–219
  7. Zhao KL, Shi XH, Jiang GL, et al. Late-course accelerated hyperfractionated radiotherapy for localized esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2004;60:123–129
  8. Wu VWC, Kwong DLW. Inverse planning in three-dimensional conformal and intensity-modulated radiotherapy of mid-thoracic oesophageal cancer. Br J Radiol. 2004;77:568–572
  9. Komaki R, Liao Z, Forster K, Lee HK, Stevens CW, Cox JD. Target definition and contouring in carcinoma of the lung and esophagus. Rays. 2003;28:225–236
  10. American Joint Committee on Cancer. (American Joint Committee on Cancer) AJCC cancer staging manual. 6th ed.. Philadelphia: Lippincott-Raven; 2002;p. 91–8
  11. International Commission of Radiation Units and Measurements “Prescribing, recording and reporting photon beam therapy, Report No. 50”. Bethesda, MD: ICRU; 1993.
  12. Trevor L, Craig E, Kally Y, et al. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol. 2006;78:254–261
  13. Wu KL, Jiang GL, Qian H, et al. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial. Int. J Radiat Oncol Biol Phys. 2003;57:1336–1344
  14. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122
  15. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–1346
  16. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226–234
  17. Liao Z, Cox JD, Komaki R. Radiochemotherapy of esophageal cancer. J Thorac Oncol. 2007;2:553–568
  18. Smith TJ, Ryan LM, Douglass HO, et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys. 1998;42:269–276
  19. Ajani JA, Walsh G, Komaki R, et al. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer. 2004;100:2347–2354
  20. Withers HR, Peters LJ. Basic principles of radiotherapy: basic clinical parameters. In:  Fletcher GA editors. Textbook of radiotherapy. 3rd ed.. Philadelphia: Lea & Febiger; 1980;p. 180
  21. Zhang Z, Liao Z, Jin J, et al. Dose–response relationship in locoregional control for patients with stage II–III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys. 2005;61:656–664
  22. Ancona E, Ruol A, Santi S, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer. 2001;91:2165–2174
  23. Gao XS, Qiao XY, Wu FP, et al. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. Int J Radiat Oncol Biol Phys. 2007;67:389–396
  24. Ma GW, Zhang X, Wang JY, et al. A study of molecular resection margins for esophageal squamous cell carcinoma using large pathologic sections. Chin J Clin Oncol. 2006;3:315–321[Chinese]

PII: S0167-8140(09)00608-2

doi: 10.1016/j.radonc.2009.10.014

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 454-457 , December 2009

Article Tools

* Image Usage & Resolution